|
|
||||||||
Articles |
Insulin receptor substrate 1 (IRS-1) gene polymorphisms have been identified in type 2 diabetic patients; however, it is unclear how such polymorphisms contribute to the development of diabetes. Here we introduced obesity in heterozygous IRS-1 knockout (IRS-1(+/-)) mice by gold-thioglucose (GTG) injection and studied the impact of reduced IRS-1 expression on obesity-linked insulin resistance. GTG injection resulted in approximately 30% weight gain in IRS-1(+/-) and wild type (WT) mice, compared with saline-injected controls. There was no difference in insulin sensitivity between lean IRS-1(+/-) and lean WT. Elevated fasting insulin levels but no change in fasting glucose were noted in obese IRS-1(+/-) and WT compared with the respective lean controls. Importantly, fasting insulin in obese IRS-1(+/-) was 1.5-fold higher (P<0.05) than in obese WT, and an insulin tolerance test showed a profound insulin resistance in obese IRS-1(+/-) compared with obese WT. The islets of obese IRS-1(+/-) were 1.4-fold larger than those of obese WT. The expression of insulin receptor and IRS-1 and IRS-2 was decreased in obese IRS-1(+/-), which could in part explain the profound insulin resistance in these mice. Our results suggest that IRS-1 is the suspected gene for type 2 diabetes and its polymorphisms could worsen insulin resistance in the presence of other additional factors, such as obesity.
This article has been cited by other articles:
![]() |
N. M. Ramocki, H. R. Wilkins, S. T. Magness, J. G. Simmons, B. P. Scull, G. H. Lee, K. K. McNaughton, and P. K. Lund Insulin Receptor Substrate-1 Deficiency Promotes Apoptosis in the Putative Intestinal Crypt Stem Cell Region, Limits Apcmin/+ Tumors, and Regulates Sox9 Endocrinology, January 1, 2008; 149(1): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Ruffolo, P. K. A. Forsell, X. Yuan, S. Desmarais, J. Himms-Hagen, W. Cromlish, K. K. Wong, and B. P. Kennedy Basal Activation of p70S6K Results in Adipose-specific Insulin Resistance in Protein-tyrosine Phosphatase 1B / Mice J. Biol. Chem., October 19, 2007; 282(42): 30423 - 30433. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hennige, U. Ozcan, T. Okada, U. S. Jhala, M. Schubert, M. F. White, and R. N. Kulkarni Alterations in growth and apoptosis of insulin receptor substrate-1-deficient {beta}-cells Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E337 - E346. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. McCurdy, R. T. Davidson, and G. D. Cartee Calorie restriction increases the ratio of phosphatidylinositol 3-kinase catalytic to regulatory subunits in rat skeletal muscle Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E996 - E1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sugita, M. Fujimoto, T. Yasukawa, N. Shimizu, M. Sugita, S. Yasuhara, J. A. J. Martyn, and M. Kaneki Inducible Nitric-oxide Synthase and NO Donor Induce Insulin Receptor Substrate-1 Degradation in Skeletal Muscle Cells J. Biol. Chem., April 8, 2005; 280(14): 14203 - 14211. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R Almon, D. C DuBois, J. Y Jin, and W. J Jusko Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle J. Endocrinol., January 1, 2005; 184(1): 219 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, V. Chang, S. B. Joseph, C. Trujillo, S. Bassilian, M. F. Saad, W. N. P. Lee, and I. J. Kurland Peroxisomal Proliferator-Activated Receptor {alpha} Deficiency Diminishes Insulin-Responsiveness of Gluconeogenic/Glycolytic/Pentose Gene Expression and Substrate Cycle Flux Endocrinology, March 1, 2004; 145(3): 1087 - 1095. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |